Key result
The developed pp62-iELISA demonstrated 90.91% relative sensitivity and 98.78% relative specificity for detecting ASFV antibodies when compared to a commercial ELISA kit.
Why the study?
African swine fever detection volume is huge and more sensitive and accurate detection techniques are needed for the market.
Effect estimate: 90.91% sensitivity, 98.78% specificity
The developed indirect ELISA using recombinant pp62 protein provides an accurate, rapid, and economical method for detecting ASFV antibodies in pig serum.
Supports further ASFV serodiagnostic development; leaves open routine use pending prospective validation.
African swine fever (ASF) is a highly detrimental viral disease caused by African swine fever virus (ASFV). The occurrence and prevalence of this disease have become a serious threat to the global swine industry and national economies. At present, the detection volume of African swine fever is huge, more sensitive and accurate detection techniques are needed for the market. pp62 protein, as a protein in the late stage of infection, has strong antigenicity and a high corresponding antibody titer in infected pigs. In this study, the CP530R gene was cloned into expression vector pET-28a to construct a prokaryotic expression plasmid, which was induced by IPTG to express soluble pp62 protein. Western blot analysis showed that it had great reactivity. Using the purified recombinant protein as an antigen, an indirect ELISA method for detecting ASFV antibody was established. The method was specific only to ASFV-positive serum, 1:1600 diluted positive serum could still be detected, and the coefficients of variation (CV) of the intra assay and inter assay were both <10%. It turns out that the assays had excellent specificity, sensitivity, and repeatability. This provides an accurate, rapid, and economical method for the detection of ASFV antibody in clinical pig serum samples.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2022) studied African swine fever virus (ASFV) infection (n=350). pp62-iELISA vs. Commercial ELISA kit (ID. Vet) was evaluated on Relative sensitivity and specificity compared to commercial kit (90.91% sensitivity, 98.78% specificity). The developed pp62-iELISA demonstrated 90.91% relative sensitivity and 98.78% relative specificity for detecting ASFV antibodies when compared to a commercial ELISA kit.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: